tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Valneva selloff on FDA suspension overdone, says H.C. Wainwright
PremiumThe FlyValneva selloff on FDA suspension overdone, says H.C. Wainwright
2M ago
Valneva price target lowered to $14 from $18 at Jefferies
Premium
The Fly
Valneva price target lowered to $14 from $18 at Jefferies
2M ago
Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ
Premium
The Fly
Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ
2M ago
Valneva’s Chikungunya Vaccine IXCHIQ® Gains Health Canada Approval
PremiumCompany AnnouncementsValneva’s Chikungunya Vaccine IXCHIQ® Gains Health Canada Approval
2M ago
Valneva SE Reports Strong Revenue Growth in 2025
Premium
Company Announcements
Valneva SE Reports Strong Revenue Growth in 2025
2M ago
Valneva Reports Strong Revenue Growth and Strategic Advances in H1 2025
Premium
Company Announcements
Valneva Reports Strong Revenue Growth and Strategic Advances in H1 2025
2M ago
Valneva Partners with CSL Seqirus for Vaccine Distribution in Germany
PremiumCompany AnnouncementsValneva Partners with CSL Seqirus for Vaccine Distribution in Germany
4M ago
Valneva Confirms 2025 Guidance Following Successful AGM
Premium
Company Announcements
Valneva Confirms 2025 Guidance Following Successful AGM
4M ago
UK restricts use of Valneva chikungunya vaccine for safety review
Premium
The Fly
UK restricts use of Valneva chikungunya vaccine for safety review
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100